【レポートの概要（一部）】
1. Report Overview
1.1 The OTC Pharmaceuticals Market Overview
1.2 OTC Pharmaceuticals Market Segmentation
1.3 Why You Should Read This Report
1.4 How This Report Delivers
1.5 Key Questions Answered by This Analytical Report
1.6 Who Is This Report For?
1.7 Methodology
1.8 Frequently Asked Questions (FAQ)
1.9 Associated Reports
1.10 About Visiongain
2. Introduction to OTC Pharmaceuticals
2.1 What Are OTC Pharmaceuticals?
2.2 Classification of OTC Pharmaceuticals
2.3 What are the Requirements for an OTC Pharmaceutical Drug?
2.4 OTC Switching
2.4.1 How Is a Drug Switched from Prescription to OTC?
2.5 Manufacturing and Distribution of OTC Pharmaceuticals
2.6 Regulation of OTC Pharmaceuticals
2.6.1 Regulation of OTC Pharmaceuticals in the US
2.6.2 Regulation of OTC Pharmaceuticals in Japan: Deregulating the Sales of OTCs
2.6.3 Regulation of OTC Pharmaceuticals in Europe
2.6.4 Regulation of OTC Pharmaceuticals in China
2.6.5 Regulation of OTC Pharmaceuticals in Others Countries
2.7 OTC Pharmaceuticals: Market Segmentation
2.7.1 Analgesics
2.7.1.1 Internal Analgesics
2.7.1.2 External Analgesics
2.7.2 Cough, Cold and Allergy Products
2.7.2.1 Cough and Cold Remedies
2.7.2.2 Anti-Allergy Products
2.7.3 Dermatological Products
2.7.3.1 Minor Cuts and Wounds
2.7.3.2 Acne
2.7.3.3 Rashes, Itchy Skin, and Dermatitis/Eczema
2.7.3.4 Cold Sores
2.7.3.5 Warts
2.7.3.6 Fungal Skin Infections
2.7.3.7 Haemorrhoids
2.7.3.8 Other Dermatological Products
2.7.4 Gastrointestinal Products
2.7.4.1 Indigestion and Heartburn
2.7.4.2 Anti-Diarrhoea OTC Pharmaceuticals
2.7.4.3 Laxatives
2.7.4.4 Anti-Emetic OTC Pharmaceuticals
2.7.4.5 Anti-Obesity OTC Pharmaceuticals
2.7.5 Eye Care
2.7.5.1 Dry Eye Syndrome
2.7.5.2 Bacterial Conjunctivitis
2.7.5.3 Ocular Allergy and Allergic Conjunctivitis
2.7.5.4 Treatment of Ocular Allergy/ Allergic Conjunctivitis
2.7.6 Smoking Cessation Aids
2.7.7 Other OTC Products
2.7.8 Vitamins, Minerals and Supplements
3. The World OTC Pharmaceutical Market 2016-2026
3.1 The World OTC Pharma Market in 2014 and 2015
3.1.1 OTC Pharma Market Segmentation in 2015 and 2016
3.1.2 Leading OTC Pharma Brands
3.1.3 Leading Companies in the OTC Market in 2014 and 2015
3.2 The World OTC Pharma Market: Sales Forecast 2016-2026
3.2.1 The World OTC Pharma Market, 2016-2026: Drivers and Restraints
3.3 OTC Pharma Market Segments: Sales Forecasts, 2016-2026
3.3.1 CAGRs by OTC Segment, 2015-2025
3.3.2 Changing Market Shares by OTC Segment, 2016-2026
3.3.3 Cough, Cold and Allergy OTC Market: Sales Forecast 2016-2026
3.3.4 Analgesics OTC Market: Sales Forecast 2016-2026
3.3.5 Gastrointestinal OTC Market: Sales Forecast 2016-2026
3.3.6 Dermatological OTC Market: Sales Forecast 2016-2026
3.3.7 Eye Care OTC Market: Sales Forecast 2016-2026
3.3.8 Smoking Cessation OTC Market: Sales Forecast 2014-2026
3.3.9 Other OTC Market: Sales Forecast 2016-2026
4. The Leading National Markets 2016-2026
4.1 Regional Breakdown of the World OTC Pharma Market in 2014 and 2015
4.2 The World OTC Pharmaceutical Market: Regional Forecast 2016-2026
4.3 Changing Market Shares of Leading National Markets: Emerging Dominance of China
4.4 The US OTC Pharmaceutical Market Sales Forecast, 2016-2026
4.4.1 The US OTC Pharma Market: Financial Incentives to Using OTC Drugs
4.4.2The US OTC Pharma Market: Leading Companies
4.5 The Japanese OTC Pharmaceutical Market Sales Forecast, 2015-2025
4.5.1 The Japanese OTC Pharma Market: Deregulation could Stimulate Growth
4.5.2The Japanese OTC Pharma Market: Leading Companies
4.6 The EU5 OTC Pharma Market in 2014 and 2015
4.6.1 Changing Market Shares of the EU5 OTC Pharmaceuticals Market
4.6.2 The EU5 OTC Market Sales Forecast, 2016-2026
4.6.3 The EU5 OTC Pharma Market: Leading Companies
4.6.4 The German OTC Pharmaceutical Market Sales Forecast, 2016-2026
4.6.5 The UK OTC Pharmaceutical Market Sales Forecast, 2015-2025
4.6.5.1 The UK’s Liberal OTC Regulations
4.6.6 The French OTC Pharmaceutical Market Sales Forecast, 2016-2026
4.6.6.1 OTC Drugs: A French Monopoly System
4.6.7 The Italian OTC Pharmaceutical Market Sales Forecast, 2015-2025
4.6.8 The Spanish OTC Pharmaceutical Market Sales Forecast, 2016-2026
4.7 The Chinese OTC Pharmaceutical Market Sales Forecast, 2016-2026
4.7.1 The Chinese OTC Pharma Market: Leading Companies
4.7.2 The Role of Traditional Chinese Medicines (TCM) in the Chinese OTC Market
4.8 The Brazilian OTC Pharmaceutical Market Sales Forecast, 2016-2026
4.8.1 The Brazilian OTC Pharma Market: An Overview
4.9 The Russian OTC Pharmaceutical Market Sales Forecast, 2016-2026
4.9.1 The Russian OTC Pharma Market: Overview
4.10 The Indian OTC Pharmaceutical Market Sales Forecast, 2016-2026
4.10.1 The Indian OTC Pharma Market: An Overview
4.11 The Mexican OTC Pharmaceutical Market Sales Forecast, 2016-2026
4.12 The Rest of the World OTC Pharmaceutical Market Sales Forecast, 2016-2026
5. Leading Companies in the OTC Pharma Market 2016-2026
5.1 Leading OTC Pharmaceutical Manufacturers, 2015
5.1.1 Leading OTC Pharmaceutical Manufacturers after completed Transactions, 2015
5.2 GSK
5.2.1 GSK Consumer Healthcare Unit: Historical Activity
5.2.2 GSK Consumer Healthcare Formed by a Joint-Venture Undertaken by GSK and Novartis
5.2.3 GSK/Novartis: Additional Transactions
5.2.4 GSK Consumer Healthcare: OTC Sales Forecast, 2015-2026
5.2.5 Flonase Launched in US
5.2.6 Panadol
5.2.7 Voltaren Gel
5.2.7.1 Voltaren Gel: Sales Forecast 2015-2025
5.2.8 Alli: A Beleaguered Brand
5.2.9 GSK Smoking Cessation Products
5.3 Novartis (OTC Joint Venture with GSK)
5.3.1 Novartis: Transformational Year
5.4 Bayer
5.4.1 Acquisition of Merck’s Consumer Care Business, 2014
5.4.2 Bayer Acquires Dihon in 2014
5.4.3 Bayer: OTC Sales Forecast, 2014-2025
5.4.4 Bayer Aspirin
5.4.5 Bayer Aspirin: Sales Forecast 2016-2026
5.4.6 Claritin OTC (Loratadine)
5.5 Merck & Co (Consumer Care Segment Acquired by Bayer)
5.6 Johnson and Johnson
5.6.1 FDA Governance of McNeil Manufacturing Activity
5.6.2 Johnson & Johnson: OTC Sales Forecast, 2014-2026
5.6.3 Rhinocort Allergy Spray
5.6.4 Tylenol
5.6.5 Nicorette
5.7 Perrigo
5.7.1 Perrigo: OTC Sales Forecast, 2014-2026
5.7.2 Perrigo Benefits from Challenges Faced by J&J
5.7.3 Perrigo: Growth by Acquisition
5.7.4 Perrigo Acquires Omega Pharma
5.7.5 Perrigo Acquires GSK Portfolio
5.7.6 Perrigo Expands Mexican Capacity and Capabilities
5.7.7 Mylan’s Hostile Takeover Bid
5.8 Pfizer
5.8.1 Pfizer: OTC Sales Forecast, 2015-2025
5.8.2 Pfizer Announces Merger with Allergan
5.8.3 Pfizer Acquires Rights to AstraZeneca’s OTC Nexium
5.8.4 Pfizer: Bulking up Their OTC Product Portfolio
5.8.5 Advil
5.9 Procter & Gamble
5.9.1 PGT Healthcare- Procter& Gamble’s Joint Venture with Teva
5.9.2 Prilosec OTC
5.9.3 Major Plans for Divestment Including OTC Products
5.10 Reckitt Benckiser
5.10.1 Reckitt Benckiser: OTC Sales Forecast, 2014-2026
5.10.2 Internal Growth by “Power” Brand Extensions: Mucinex
5.10.3 Expanding Presence in Emerging Markets through Acquisition
5.11 Sanofi
5.11.1 Sanofi Focuses on Long-Term Growth with Potential Boehringer Ingelheim Asset Swap Pending Completion Q4 2016
5.11.2 Sanofi: Acquisition of OTC Products from J&J
5.11.3 Sanofi: Launch of Nasacort
5.11.4 Sanofi: OTC Sales Forecast, 2014-2026
5.12 Boehringer Ingelheim
5.12.1 Boehringher Ingelhime: OTC Sales Forecast 2014-2026
5.13. Mylan Enter OTC Market
6. OTC Switching and Potential Future of OTC Drugs
6.1 OTC Switching: An Overview
6.1.1 What is OTC Switching?
6.1.2 Which Products Will Switch?
6.1.3 How Does OTC Switching Occur?
6.1.4 How Does OTC Switching Affect the OTC Pharma Market?
6.1.5 Opposition to OTC Switching
6.2 OTC Switching Activity, 2002-2015
6.2.1 OTC Switching: Downward Trend
6.2.2 The FDA NSURE Initiative: Reversing the Downward Trend in Rx-to-OTC Switches
6.3 Potential Candidates for OTC Switching 2016-2026
6.4 Cough, Cold and Allergy: OTC Switches
6.4.1 First-Generation Antihistamines
6.4.2 Allegra (fexofenadine)
6.4.3 Clarinex (desloratadine)
6.4.4 Rhinocort Allergy Spray (budesonide): Latest Nasal Corticosteroid Approval
6.4.5 Flixotide/Flonase (fluticasone): Latest Nasal Corticosteroid Approval
6.4.6 Nasacort (triamcinolone): First in Class U.S. OTC Approval
6.5 Analgesics: OTC Switch Limitations
6.5.1 Triptans: The U.S. Will Remain Cautious
6.5.2 NSAIDs for Arthritis: Safety Concerns Incites Reverse-Switching
6.5.3 Other Analgesics
6.6 Gastrointestinals: OTC Switches
6.6.1 H2-Receptor Blockers
6.6.2 Proton Pump Inhibitors (PPIs)
6.6.2.1 Omeprazole
6.6.2.2 Lansoprazole
6.6.2.3 Pantoprazole
6.6.2.4 Esomeprazole: 2014 U.S. FDA Approval for OTC Use
6.6.2.5 Rabeprazole
6.6.3 Anti-Obesity Drugs
6.7 Dermatologicals: OTC Switches
6.7.1 Antivirals for Oral Herpes Simplex
6.8 Anticholinergics for Incontinence: OTC Switches
6.9 Oral Contraceptives: An OTC Switch Can have Significant Economic Benefits
6.10 High Demand for OTC Cholesterol-Lowering Drugs
6.10.1 Lipitor (atorvastatin): Testing Times for Pfizer
6.10.2 Zocor Heart Pro (simvastatin) in the UK
6.10.3 OTC Statins: U.S. Historical Setbacks
6.11 Other Potential OTC Switch Categories
6.11.1 High Blood Pressure: Thiaside Diuretics
6.11.2 Erectile Dysfunction: Viagra (sildenafil), Cialis (tadalafil)
6.11.3 Osteoporosis: (Bisphosphonates) An Undertreated Disease, but a Very Unlikely OTC Switch
6.11.4 Insomnia: Silenor (doxepin)
7. Qualitative Analysis of the OTC Pharma Market, 2016-2026
7.1 SWOT Analysis of the OTC Pharmaceutical Market
7.2 Strengths
7.2.1 Healthcare Systems, Third Party Payers, and Manufacturers: All have Incentives to Push for OTC Drug Consumption
7.2.1.1 Manufacturers Can Reap OTC Sales Benefits
7.2.1.2 Third Party Payers: Reducing the Cost Burden
7.2.1.3 Healthcare Systems: Pushing the Cost to the Consumer
7.2.2 Many Pharma Companies Have a Strong Potential OTC Portfolio
7.2.3 Regulators Are Encouraging OTC Approvals
7.2.4 Effective Distribution Networks Due to Expansion of Retail Pharmacy and Alternative Distributors
7.2.5 Deterring the Consumption of Counterfeit Drugs
7.2.6 Cultural Changes Will Support Self-Medication with OTC Medicines
7.3 Weaknesses
7.3.1 Pharma Companies Remain Focused on Prescription Drugs
7.3.2 Manufacturing Problems Affects Sales and Reputation of OTC Drugs
7.3.3 OTC Products are Vulnerable to Price Controls by Governments
7.3.4 Downward Cost Pressures of OTC Drugs
7.4 Opportunities
7.4.1 Demographic and Economic Changes Will Create Growth Opportunities
7.4.2 New OTC Switch Categories
7.4.3 Strong Growth in Emerging Markets
7.4.4 New Healthcare Technologies May enable OTC Approvals
7.4.5 Opportunities to Drive Sales via Social Media and Online Marketing
7.4.6 Self Medication can Reduce the Under Treatment of Disease
7.5 Threats
7.5.1 Competition from Private-Label Brands Will Reduce Profitability
7.5.2 Regulatory Concerns Over Safety and Misuse may Lead to Withdrawal of Products
7.5.3 Resistance to OTC Switching from Some Groups in Certain Countries
7.6 Porter’s Five Forces Analysis of the OTC Pharmaceutical Market
7.6.1 Rivalry Among Competitors [High]
7.6.2 Threat of New Entrants [Medium]
7.6.3 Power of Suppliers [Low]
7.6.4 Power of Buyers [Medium]
7.6.5 Threats of Substitutes [Medium]
8. Conclusions
8.1 The World OTC Pharma Market in 2014-2015
8.1.1 The Leading OTC Product Categories
8.1.2 Leading OTC Pharma Brands, 2015
8.1.3 Leading OTC Manufacturers
8.1.4 Leading National Markets: Emerging Market Represent a Large Proportion
8.1.5 The Global OTC Market Growth Factors
8.1.6 Potential OTC Switching, 2016-2026
8.1.7 Emerging OTC Markets
8.2 Concluding Remarks
Appendices
Visiongain’s Bespoke Research Service
Some Associated Reports
Visiongain Report Sales Order Form
About Visiongain
Report Evaluation Form
【レポート販売概要】
■ タイトル：OTC医薬品（市販薬）の世界市場予測2016-2026■ 英文：World OTC Pharmaceutical Market Forecast 2016-2026
■ 発行日：2016年3月
■ 調査会社：visiongain
■ 商品コード：VGAIN6041529
■ 調査対象地域：グローバル
- 東南ヨーロッパのLTE市場（LTE in the Southeast Europe: Contracts, Operator Reviews, Spectrum Strategies, Subscriptions, Pricing and Forecasts 2011-2015）The LTE industry is growing at a rapid pace worldwide and by 2015 it is estimated that South Eastern Europe Region will have 6.9 Million subscriptions which will represent 1.7% of the worldwide market share. Future developments of LTE networks will be reliant on spectrum re-farming by regulators and also on finalizing the analogue switchover due to a need for digital dividend frequencies. LTE on s …
- 世界の抗生物質市場：ベータラクタム、マクロライド、アミノグリコシド、フェニコール、キノロン、スルホンアミド、テトラサイクリン等About Antibiotics Antibacterial drugs are chemical compounds used to kill or inhibit the growth of bacteria. The term "antibiotic" is often used synonymously with antibacterial; however, the term "antibiotic" was originally coined to refer to the antibacterial compounds of microbial origin. Antibacterial acts via various mechanisms such as the inhibition of cell wall synthesis, the inhibition of n …
- Sui Northern Gas Pipelines Limited：石油・ガスバリューチェーン分析レポート2013Sui Northern Gas Pipelines Limited Analysis Across the Oil and Gas Value Chain Report, 2013 Update Summary "Sui Northern Gas Pipelines Limited" Analysis Across the Oil and Gas Value Chain is an essential source for data, analysis and strategic insight into “Sui Northern Gas Pipelines Limited”. The report provides key information relating to oil and gas assets of the company along with its operatio …
- 煙感知器の世界市場：光電式煙感知器、イオン化煙感知器、二重センサ式煙感知器MarketsandMarkets forecasts the smoke detector market to grow from USD 1.31 Billion in 2015 to USD 2.52 Billion by 2022, at a CAGR of 9.2% between 2016 and 2022. The smoke detector market is driven by factors such as increasing number of government mandate policies to install smoke alarms in residential sector, increased fire-related expenditure of various enterprises, and rise in deaths & loss of …
- 坐骨神経痛治療の世界市場2019-2023About this market Sciatica is often confused with general back pain. Sciatica can cause long-term pain in the lower back if the condition is left untreated. Hence, various government and non-governmental organizations are initiating certain programs to increase awareness among people about the condition and avoid delay in diagnosis. For instance, Ortholnfo, the patient education site of the Americ …
- 世界の自動車用熱システム（サーマルシステム）市場動向（2014-2018）About Automotive thermal systems Automotive thermal systems are divided into four basic categories—HVAC systems, powertrain cooling systems, compressors, and fluid transport systems. Automotive HVAC systems are systems that are used to provide heat, ventilation, and air conditioning in vehicles to maintain good air quality and ensure thermal comfort for passengers. Powertrain cooling systems are u …
- 雪崩安全用品の世界市場：エアバッグ、無線電話機、プローブ、シャベルAbout Avalanche Safety Gear Avalanche safety gear has gained popularity among backcountry and sidecountry travelers. The growth in the global snow sports industry is positively impacting the avalanche safety gear market. Industry participants, including equipment manufacturers, governments, and forecasters, are collaborating to increase awareness about avalanche safety. Technavio’s analysts foreca …
- 世界の固定翼VTOL UAV市場：業種別（軍事、政府＆法執行機関、商業）、推進力別（電気、ハイブリッド、ガソリン）、動作モード別（VLOS、EVLOS、BVLOS）、持久力別、範囲別、MTOW別、地域別“The fixed-wing VTOL UAV market is projected to grow at a CAGR of 19.7% during the forecast period.” The fixed-wing VTOL UAV market is projected to grow from USD 498 million in 2019 to USD 3,583 million by 2030, at a CAGR of 19.7% during the forecast period. The increasing adoption of fixed-wing VTOL UAVs in the commercial and military verticals is one of the most significant factors expected to d …
- 世界の塩素酸ソーダ市場2015The Global Sodium Chlorate Industry 2015 Market Research Report is a professional and in-depth study on the current state of the Sodium Chlorate industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The Sodium Chlorate market analysis is provided for the international markets including development trends, co …
- リヨセル繊維の世界市場2015-2019About lyocell fiber Lyocell is a man-made fiber that is derived from cellulose. It is manufactured through a solvent spinning technique by closed loop method, where cellulose undergoes a chemical change. Lyocell fibers are significantly used in textiles and are made from wood pulp. Lyocell fiber is the strongest cellulose fiber when dry and known for its durable property. Technavio's analysts fore …
- アクセス制御における虹彩認証の世界市場2016-2020About Iris Recognition Iris recognition is one of the most secure and accurate modes of biometrics used for security and surveillance in sectors such as government, military and defense, healthcare, banking and finance, consumer electronics, travel and immigration, and automotive. Since its existence in 1994, many countries across the world have deployed iris recognition technology for cross-borde …
- 世界のDRAM市場動向（2012-2016）TechNavio's analysts forecast the Global DRAM market to grow at a CAGR of 4.3 percent over the period 2012-2016. One of the key factors contributing to this market growth is the high demand for DRAM in smartphones. The Global DRAM market has also been witnessing rapid technological advancement. However, declining ASPs of DRAMs could pose a challenge to the growth of this market. TechNavio's report …
- 自動車用アクチュエーターの世界市場予測：車両別、用途別、高速道路車両別、作動別“Increase in production of passenger cars and commercial vehicles is a significant factor for the growth of the automotive actuators market globally”The global automotive actuators market is projected to reach USD 39.5 billion by 2027 from an estimated USD 22.8 billion in 2019, at a CAGR of 7.1% during the forecast period. The automotive actuators market is growing in tandem with the constant grow …
- 2型糖尿病治療薬の世界市場：インスリン、DPP-4阻害薬、GLP-1受容体作動薬、 SGLT-2阻害薬About Type 2 Diabetes Diabetes, often referred to as diabetes mellitus, is a metabolic disease in which the patients' blood glucose levels remains high. Depending on the cause of development of diabetes, it can be divided into three types: • Type 1 diabetes (or insulin-dependent diabetes mellitus): In this condition, the pancreas do not produce the required amount of insulin, leading to high blood …
- 石油・ガス部門におけるビッグデータの世界市場2018-2022About Big Data Market in the Oil and Gas Sector Big data includes software and services that are utilized to handle extremely massive volumes of information stored inside enterprise systems. Big data analytics helps enterprises optimize their business decisions and innovate new business models, products, and services offerings based on the data collected. Technavio’s analysts forecast the Global B …
